Compare ORIO & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIO | CCM |
|---|---|---|
| Founded | N/A | 1997 |
| Country | Canada | China |
| Employees | 188 | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 19.0M |
| IPO Year | N/A | 2009 |
| Metric | ORIO | CCM |
|---|---|---|
| Price | $0.85 | $4.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.2K | ★ 42.3K |
| Earning Date | 03-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.52 | N/A |
| Revenue Next Year | $5.07 | N/A |
| P/E Ratio | $4.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $3.18 |
| 52 Week High | $1.40 | $10.77 |
| Indicator | ORIO | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 46.88 |
| Support Level | $0.84 | $4.41 |
| Resistance Level | $0.98 | $5.63 |
| Average True Range (ATR) | 0.06 | 0.47 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 25.51 | 18.82 |
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.